- Home
- FROG vs ACLX Comparison
FROG vs ACLX Comparison
Compare FROG & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FROG
- ACLX
- Stock Information
- Founded
- FROG 2008
- ACLX 2015
- Country
- FROG United States
- ACLX United States
- Employees
- FROG N/A
- ACLX N/A
- Industry
- FROG Computer Software: Prepackaged Software
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- FROG Technology
- ACLX Health Care
- Exchange
- FROG Nasdaq
- ACLX Nasdaq
- Market Cap
- FROG 3.6B
- ACLX 3.8B
- IPO Year
- FROG 2020
- ACLX 2022
- Fundamental
- Price
- FROG $41.92
- ACLX $71.14
- Analyst Decision
- FROG Strong Buy
- ACLX Strong Buy
- Analyst Count
- FROG 19
- ACLX 14
- Target Price
- FROG $41.17
- ACLX $114.75
- AVG Volume (30 Days)
- FROG 849.9K
- ACLX 420.2K
- Earning Date
- FROG 08-07-2025
- ACLX 08-11-2025
- Dividend Yield
- FROG N/A
- ACLX N/A
- EPS Growth
- FROG N/A
- ACLX N/A
- EPS
- FROG N/A
- ACLX N/A
- Revenue
- FROG $450,584,000.00
- ACLX $76,809,000.00
- Revenue This Year
- FROG $19.77
- ACLX N/A
- Revenue Next Year
- FROG $15.14
- ACLX $108.81
- P/E Ratio
- FROG N/A
- ACLX N/A
- Revenue Growth
- FROG 21.66
- ACLX N/A
- 52 Week Low
- FROG $22.91
- ACLX $47.86
- 52 Week High
- FROG $45.99
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- FROG 49.19
- ACLX 58.77
- Support Level
- FROG $40.94
- ACLX $69.30
- Resistance Level
- FROG $45.99
- ACLX $74.43
- Average True Range (ATR)
- FROG 1.39
- ACLX 2.53
- MACD
- FROG 0.16
- ACLX 0.02
- Stochastic Oscillator
- FROG 35.91
- ACLX 58.41
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.